We heartily welcome all the participants throughout the globe to participate in the conference titled 12thInternational Conference on Pharmacoepidemiology and Clinical Research which is scheduled to commence on November 28-29, 2019 at Helsinki, Finland. This event would be a great opportunity to gather knowledge as well as experience in the field of pharmacy.
Pharmacoepidemiology 2019 Conference is a multidisciplinary program with far-reaching cooperation with individuals from around the world concentrated on finding out about pharmacology, epidemiology, clinical research and its advances. This stage is your best chance to achieve the biggest get-together of members from Pharmacist and Clinical Pharmacist people group that is from the scholarly community, clinical scientists, medicinal gatherings, social orders, related affiliations and furthermore from drug specialist, government offices and therapeutic gadget businesses.
Pharmacoepidemiology 2019 describes the activities of the pharmacists done in order to elevate pharmaceutical care and medications for the promotion of health care and disease prevention. Pharmacoepidemiology has a promising history of upgrading the practices through new approaches and innovations. Clinical Pharmacy is more of a patient-centered discipline. The Clinical pharmacy field is not bound to any certain specific areas but has a reach towards other medical fields such as Cardiology, Nephrology, Oncology internal medicine and much more.
Motives to attend:
- A wide track of exhibitors to showcase the new and emerging technologies.
- Keynote presentation along with interactions to galvanize the scientific community.
- Triumph of Awards, Certificates recognizes your commitment to your profession to encourage the nascent research.
- Young Scientist/ Investigators Award geared towards best budding young research.
- Links to the political marketing resources in order to expand your business and research network.
- Platform to global investment community to connect with stakeholders in Pharma sector.
- Workshop and symposiums to reach the largest assemblage of participants from the Pharma community.
Why to Attend???
12th International Conference on Pharmacoepidemiology and Clinical Research scheduled during November 28-29, 2019 in Helsinki, Finland is organised aiming to bring together leading academic professors, scientists, researchers and students to exchange, share their experiences and research results on all aspects of Pharmacoepidemiology and Clinical research . It also provides a premier interdisciplinary pavement for Pharma, Regulatory, Drug Designing and clinical trial industries to represent their technological innovations and discuss the most recent approaches, trends, and concerns as well as practical challenges encountered and solutions adopted in the fields of Pharmacoepidemiology & Clinical research.
Pharmaceutical research provides a profitable business opportunity to several pharmaceutical and biotech companies as these technologies have wide application areas such as drug discovery and research followed by New drug delivery systems. Pharmacoepidemiology is the study of the utilization and effects of drugs in large numbers of people; it provides an estimate of the probability of beneficial effects of a drug in a population and the probability of adverse effects. It can be called a bridge science spanning both clinical pharmacology and epidemiology Part of the task of clinical pharmacology is to provide a risk benefit assessment by effects of drugs in patients:
1.Doing the studies needed to provide an estimate of the probability of beneficial effects on populations.
2.Or assessing the probability of adverse effects on populations.
Pharmacoepidemiology concentrates on clinical patient outcomes from therapeutics by using methods of clinical epidemiology and applying them to understanding the determinants of beneficial and adverse drug effects, effects of genetic variation on drug effect, duration-response relationships, clinical effects of drug-drug interactions, and the effects of medication non-adherence. Pharmacovigilance is a part of pharmacoepidemiology that involves continual monitoring, in a population, for unwanted effects and other safety concerns arising in drugs that are already on the market. Pharmacoepidemiology sometimes also involves the conduct and evaluation of programmatic efforts to improve medication use on a population basis.
Epidemiology is the study of the distribution and determinants of diseases and other health states in populations. Epidemiological studies can be divided into two main types:
1.Descriptive epidemiology describes disease and/or exposure and may consist of calculating rates, e.g., incidence and prevalence. Such descriptive studies do not at this time use health control groups and can only generate hypotheses,but not test them. Studies of drug use would generally fall under descriptive studies.
2.Analytic epidemiology includes two types of studies: observational studies, such as case-control and cohort studies, and experimental studies which include clinical trials or randomized clinical trials. The analytic studies compare an exposed group with a control group and usually designed as hypothesis testing by studies.
Pharmacoepidemiology and Clinical research Congress includes a wide range of Keynote presentations, Oral talks, Poster presentations, Symposia, Workshops, Exhibitions and extensive networking and B2B(Business to Business) interactions.
Mark your dates to meet the experts & join the critical discussions at Pharmacoepidemiology and Clinical Research Congress scheduled during November 28-29, 2019 in Helsinki, Finland. Register now to unleash Advanced Clinical research and compliance in the arena of Pharmacoepidemiology.